(Q47234278)
Statements
1 reference
High-dose, frequently administered interferon beta therapy for relapsing-remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study (English)
1 reference
Pierangelo Barbero
1 reference
Elisabetta Verdun
1 reference
Mauro Bergui
1 reference
Antonio Pipieri
1 reference
Marinella Clerico
1 reference
Angele Cucci
1 reference
Alessandra Ricci
1 reference
Bruno Bergamasco
1 reference
Luca Durelli
1 reference
1 July 2004
1 reference
222
1 reference
1-2
1 reference
13-19
1 reference